JancsiTech Closes RMB Tens of Millions Angle+ Financing

24 sierpień 2023 Chiny, Finansowanie

Azja i Pacyfik Najświeższe wiadomości Rozwój strategiczny

China Shenzhen-based JancsiTech closes tens of millions of RMB Angle+ financing co-led by HKX Fund and Qiaodao Fund, and followed by previous investor Sequoia China Seed Fund, for technological innovation, product upgrading and talent acquisition in radiotherapy.

Founded in September 2021, JancsiTech has technology R&D centres in Shanghai and Hangzhou and is committed to becoming a pioneer in precision nuclear medicine. Its core founding team consists of domestic and international experts in nuclear medicine, nuclear physics and artificial intelligence technology from Stanford University and Alibaba.

JancsiTech’s soon-to-be-approved low-dose CT equipment has been used by many hospitals for research and trials and has been accepted by leading CT manufacturers. It has applied for approval of its radiotherapy optical surface monitoring product “Qishi”, which has been used by hospitals for research.

In the future, the company will continue to invest in the research and development of radiotherapy equipment and focus on non-invasive radiotherapy technology for superficial tumour treatment.

The Post is Available in: English – 简体中文